These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 415325)

  • 1. Effect of synthesis inhibition on the levels of brain catecholamines in barbital-dependent rats.
    Morgan WW; Huffman RD; Pfeil KA; Gonzales EG
    Psychopharmacology (Berl); 1978 Jan; 56(1):41-4. PubMed ID: 415325
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of physical dependence on barbiturates and cerebral monoamines.
    Tagashira E; Hiramori T; Urano T; Yanaura S
    Jpn J Pharmacol; 1983 Apr; 33(2):415-22. PubMed ID: 6193305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal.
    Morgan WW
    Experientia; 1976 Apr; 32(4):489-91. PubMed ID: 944644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-methyl-p-tyrosine on the incidence of spontaneous convulsions observed following barbital withdrawal.
    Morgan WW; Pfeil KA; Gonzales EG
    Neuropharmacology; 1978 Feb; 17(2):115-9. PubMed ID: 565016
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in brain levels of cyclic nucleotides and gamma-aminobutyric acid in barbiturate dependence and withdrawal.
    Lenox RH; Wray HL; Kant GJ; Hawkins TD; Meyerhoff JL
    Eur J Pharmacol; 1979 Apr; 55(2):159-69. PubMed ID: 222596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased response of cerebellar cGMP to kainate but not NMDA or quisqualate following barbital withdrawal from dependent rats.
    McCaslin PP; Morgan WW
    Eur J Pharmacol; 1989 Dec; 173(2-3):127-32. PubMed ID: 2560429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sex differences in the physical dependence on barbital in rats].
    Suzuki T; Koike Y; Yoshii T; Yanaura S
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):373-80. PubMed ID: 3825311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholaminergic involvement in the effects of amphetamine isomers on seizure susceptibility.
    Gerald MC; Gupta TK
    Eur J Pharmacol; 1977 Jan; 41(2):231-4. PubMed ID: 832677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta-9-tetrahydrocannabinol: effect on adrenal catecholamines.
    Mitra G; Poddar MK; Ghosh JJ
    Toxicol Appl Pharmacol; 1976 Sep; 37(3):517-24. PubMed ID: 973224
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical aspects of experimental barbital dependence III: effect on neural energy reserve system.
    Yanaura S; Kakuno K; Nakao K; Matsukawa K; Urano T; Tagashira E
    J Toxicol Sci; 1982 May; 7(2):135-42. PubMed ID: 6890113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nifedipine on physical dependence on barbital or diazepam in rats.
    Suzuki T; Mizoguchi H; Motegi H; Awano H; Misawa M
    J Toxicol Sci; 1995 Sep; 20(4):415-25. PubMed ID: 8531237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participant of serotonin turnover rate in the brain on barbital withdrawal convulsion.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1982 Feb; 32(1):159-67. PubMed ID: 6177889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats.
    Jänicke UA; Coper H
    Drug Alcohol Depend; 1984 Jan; 13(1):43-54. PubMed ID: 6539666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical aspects of experimental barbital dependence II: Effect on glycometabolism.
    Yanaura S; Kakuno K; Nakao K; Tagashira E
    Jpn J Pharmacol; 1983 Apr; 33(2):395-402. PubMed ID: 6684191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of rat brain protein synthesis to ethanol and sodium barbital.
    Tewari S; Greenberg SA; Do K; Grey PA
    Alcohol Drug Res; 1987; 7(4):243-58. PubMed ID: 3828001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ethanol, barbital, and lorazepam on brain monoamines in rat lines selectively outbred for differential sensitivity to ethanol.
    Hellevuo K; Kiianmaa K
    Pharmacol Biochem Behav; 1988 Jan; 29(1):183-8. PubMed ID: 3353424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 20. 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1987 Jul; 26(7A):731-5. PubMed ID: 2819762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.